Insulet
PODD
#1018
Rank
โ‚น1.588 T
Marketcap
โ‚น22,639
Share price
3.90%
Change (1 day)
25.91%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Revenue for Insulet (PODD)

Revenue in 2024 (TTM): โ‚น165.52 Billion

According to Insulet's latest financial reports the company's current revenue (TTM ) is โ‚น168.48 Billion. In 2023 the company made a revenue of โ‚น141.28 Billion an increase over the revenue in the year 2022 that were of โ‚น108.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insulet from 2006 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น165.52 B17.16%
2023 โ‚น141.28 B30.8%
2022 โ‚น108.01 B32.07%
2021 โ‚น81.78 B23.65%
2020 โ‚น66.14 B25.65%
2019 โ‚น52.64 B33.53%
2018 โ‚น39.42 B33.14%
2017 โ‚น29.61 B18.74%
2016 โ‚น24.93 B33.92%
2015 โ‚น18.62 B1.76%
2014 โ‚น18.29 B19.87%
2013 โ‚น15.26 B31.9%
2012 โ‚น11.57 B43.69%
2011 โ‚น8.05 B85.37%
2010 โ‚น4.34 B41.81%
2009 โ‚น3.06 B76.78%
2008 โ‚น1.73 B230.26%
2007 โ‚น0.52 B203.12%
2006 โ‚น0.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น198.73 B 17.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น69.47 B-58.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น335.80 B 99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.447 T 4,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.500 T 1,977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.802 T 1,563.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น3.470 T 1,959.75%๐Ÿ‡บ๐Ÿ‡ธ USA